A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Recruiting	Phase 1 / Phase 2	2025-09-23		NCT04121468

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Multiple Sclerosis Society of Canada	6
Ontario Institute for Regenerative Medicine	3
Queen's University	45
Stem Cell Network	8
The Hospital for Sick Children	162
Unity Health Toronto	104

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Hospital For Sick Children	Toronto	Canada	94